Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes

OBJECTIVE: Diabetes is the leading cause of nontraumatic lower-extremity amputations (LEAs). Identification of patients with foot ulcers at risk for amputation remains clinically challenging. Plasma copeptin, a surrogate marker of vasopressin, is associated with the risk of cardiovascular and renal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Care
Hauptverfasser: Potier, Louis, Roussel, Ronan, Marre, Michel, Bjornstad, Petter, Cherney, David Z., El Boustany, Ray, Fumeron, Frédéric, Venteclef, Nicolas, Gautier, Jean-François, Hadjadj, Samy, Mohammedi, Kamel, Velho, Gilberto
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Diabetes Association 2019
Schlagworte:
Pathophysiology/Complications
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973542/
https://ncbi.nlm.nih.gov/pubmed/31582427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1062
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge